Founded in 1984, Labcor Laboratiorios is a world-renowned industry the specialized in producing biological prostheses. Located in Belo Horizonte, the company is a national leader in cardiovascular bioprostheses and has already performed 150,000 implants throughout the world.

Labcor, which annually produces 20,000 units of valves and grafts, is present throughout Brazilian and has offices in Rio de Janeiro, São Paulo, Porto Alegre, Belo Horizonte, as well as representatives or distributors in other capital cities. Today the company exports its products to several countries such as Germany, Belgium, Argentina, Colombia, Venezuela, Peru, France, Italy, Austria, Spain, Portugal and some counties in Latin American and Asia.

Since it produced it first hear valve, Labcor has been developing cardiovascular and vascular prosthesis technology. This competence allows us to develop a portfolio rich in biotechnological products.

Today, Labcor is in the vanguard of scientific research and the discovery of solutions in developing bioprostheses, scientifically searching for solutions to save more lives.

Our scientists share their discoveries and the results of clinical tests are published in specialized periodicals and at congresses, which makes Labcor one of the most outstanding cardiovascular bioprosthesis industries in the sector.

By validating joint efforts to implement total quality, Labcor Laboratories has received certification for Good Practices in Medial Products Manufacturing (GMP) granted by Anvisa, and the ISO 13485:2003 accredited by international associations, as well as being the only company in this sector in Latin America with the CE mark in several products. We are always under detailed evaluations and constantly perfecting our products in order to create hop for a more healthful life.

All of Labcor`s efforts, together with the quality of the manufacturing environmental and the commitment of our collaborators make our prostheses an ideal alternative for the patient. With dedication and integrity we have made our work more dignifying and endorse our commitment to life.

As validation of the joint efforts involved in total quality implementation, Labcor Laboratories has been awarded the Good Manufacturing Practices for Medical Products (GMP) granted by Anvisa and the ISO 13485:2003 accreditation for international entities, in addition to being the sole company in this sector in Latin America to have the CE Mark for diverse products.

These are significant victories that show to the market our standard of quality.





Good Manufacturing Practices includes a set of measures that should be adopted by the industries to control possible sources of contamination, thus ensuring product safety and quality.




The ISO 13485:2003 is an international norm that enables organizations to implement a Quality Management System directed toward the medical device industry by establishing a policy of quality, controls and risk management.




The CE Mark is a certification that gives products a guarantee of quality in order to be sold or exported to the European market.